K. Bánki

发表

Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus‐Prone Mice

S. Landas, T. Caza, David R Fernandez, 2016, Arthritis & rheumatology.

Study of transaldolase deficiency in urine samples by capillary LC-MS/MS.

G. Vas, A. Perl, Yueming Qian, 2006, Journal of mass spectrometry : JMS.

The three‐dimensional structure of human transaldolase

G. Schneider, A. Perl, P. Gergely, 2000, FEBS letters.

Cloning and expression of the human gene for transaldolase. A novel highly repetitive element constitutes an integral part of the coding sequence.

A. Perl, K. Bánki, D. Halladay, 1994, The Journal of biological chemistry.

Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I gag-reactive autoantibodies.

D. Mattson, A. Perl, K. Bánki, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Crossing borders from Hungary to Ireland: the cross-cultural adaptation of Hungarian refugees from the 1940s and their compatriots from the 1956 Hungarian Revolution

K. Bánki, 2009 .

HRES-1/Rab4 Promotes the Formation of LC3+ Autophagosomes and the Accumulation of Mitochondria during Autophagy

D. Chudakov, A. Perl, S. Tooze, 2014, PloS one.

Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLE.

A. Perl, K. Bánki, Konrad Dziamski, 2020, Clinical immunology.

Systemic lupus erythematosus-myasthenia gravis overlap syndrome: Presentation and treatment depend on prior thymectomy.

A. Perl, Z. Oaks, K. Bánki, 2018, Clinical immunology.

Transaldolase is essential for maintenance of the mitochondrial transmembrane potential and fertility of spermatozoa

F. Middleton, A. Perl, Yueming Qian, 2006, Proceedings of the National Academy of Sciences.

CD8 T Cell-Mediated HLA-A*0201-Restricted Cytotoxicity to Transaldolase Peptide 168–176 in Patients with Multiple Sclerosis

A. Perl, W. Biddison, K. Bánki, 2005 .

Patients Retention of Antigenicity for Multiple Causes the Loss of Enzymatic Activity with Cleavage of Transaldolase by Granzyme B

J. Lieberman, A. Perl, A. Rosen, 2010 .

Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles.

J. Reveille, F. Arnett, A. Perl, 1995, Arthritis and rheumatism.

Mitochondrial hyperpolarization: a checkpoint of T-cell life, death and autoimmunity.

G. Nagy, Á. Koncz, A. Perl, 2004, Trends in immunology.

Molecular Mimicry, Altered Apoptosis, and Immunomodulation as Mechanisms of Viral Pathogenesis in Systemic Lupus Erythematosus

A. Perl, K. Bánki, 1999 .

Glutathione Levels and Sensitivity to Apoptosis Are Regulated by Changes in Transaldolase Expression*

A. Perl, E. Hutter, K. Bánki, 1996, The Journal of Biological Chemistry.

Inhibition of the catalytic activity of human transaldolase by antibodies and site‐directed mutagenesis

A. Perl, K. Bánki, 1996, FEBS letters.

Deletion of Ser-171 causes inactivation, proteasome-mediated degradation and complete deficiency of human transaldolase.

S. Vajda, A. Perl, M. S. van der Knaap, 2004, The Biochemical journal.

Human endogenous retroviral elements and autoimmunity: data and concepts.

A. Perl, K. Bánki, Andras Perl, 1993, Trends in microbiology.

Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years

N. Huang, A. Perl, Z. Oaks, 2016, Current Rheumatology Reports.

Metabolism of S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine to hydrogen sulfide and the role of hydrogen sulfide in S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine-induced mitochondrial toxicity.

L. Lash, M. W. Anders, K. Bánki, 1986, Biochemical and biophysical research communications.

The human transaldolase gene (TALDO1) is located on chromosome 11 at p15.4-p15.5.

R. Eddy, T. Shows, C. Croce, 1997, Genomics.

Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis

D. Mattson, A. Perl, E. Colombo, 1994, The Journal of experimental medicine.

Effect of p40tax trans-activator of human T cell lymphotropic virus type I on expression of autoantigens.

A. Perl, M. Nakamura, K. Bánki, 1994, AIDS research and human retroviruses.

Molecular Ordering in HIV-induced Apoptosis OXIDATIVE STRESS, ACTIVATION OF CASPASES, AND CELL SURVIVAL ARE REGULATED BY TRANSALDOLASE*

A. Perl, K. Bánki, N. Gonchoroff, 1998 .

Apoptosis and mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus.

G. Nagy, A. Perl, Yueming Qian, 2004, Methods in molecular medicine.

Metabolic switches of T-cell activation and apoptosis.

A. Perl, P. Gergely, K. Bánki, 2002, Antioxidants & redox signaling.

Genetic and metabolic control of the mitochondrial transmembrane potential and reactive oxygen intermediate production in HIV disease.

A. Perl, K. Bánki, 2000, Antioxidants & redox signaling.

Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C

Peter Gergely, Ferenc Puskas, A. Perl, 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Differential regulation of hydrogen peroxide and Fas-dependent apoptosis pathways by dehydroascorbate, the oxidized form of vitamin C.

A. Perl, P. Gergely, K. Bánki, 2002, Antioxidants & redox signaling.

Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis.

A. Perl, P. Ferrante, E. Colombo, 1997, The Journal of clinical investigation.

MITOCHONDRIAL DYSFUNCTION IN T CELLS OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

A. Perl, P. Gergely, K. Bánki, 2004, International reviews of immunology.

Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling.

A. Perl, K. Bánki, N. Gonchoroff, 1999, Journal of immunology.

Molecular Ordering in HIV-induced Apoptosis

A. Perl, E. Hutter, K. Bánki, 1998, The Journal of Biological Chemistry.

HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE

F. Middleton, D. Chudakov, M. Madaio, 2013, Annals of the rheumatic diseases.

Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus.

A. Perl, P. Gergely, P. Phillips, 2002, Arthritis and rheumatism.

Regulation of CD4 Expression via Recycling by HRES-1/RAB4 Controls Susceptibility to HIV Infection*

G. Nagy, Á. Koncz, Tiffany Telarico, 2006, Journal of Biological Chemistry.

Human T-cell leukemia virus type I or a related retrovirus in patients with mycosis fungoides/Sézary syndrome and Kaposi's sarcoma.

A. Perl, K. Bánki, B. Srivastava, 1992, Cancer research.

Human Transaldolase-associated Repetitive Elements Are Transcribed by RNA Polymerase III*

M. C. Butler, A. Perl, K. Bánki, 2000, Journal of Biological Chemistry.

Detection of lupus anticoagulant and successful anticoagulation in familial Sneddon syndrome

A. Perl, G. Hoffman, K. Bánki, 2010, Annals of the rheumatic diseases.

Cleavage of Transaldolase by Granzyme B Causes the Loss of Enzymatic Activity with Retention of Antigenicity for Multiple Sclerosis Patients

J. Lieberman, D. Martinvalet, A. Perl, 2010, The Journal of Immunology.

Sclerosis Patients Epitopes Identified by Autoantibodies of Multiple Human Transaldolase and Cross-Reactive Viral

S. Vajda, L. Otvos, A. Perl, 2011 .

Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients.

S. Vajda, L. Otvos, A. Perl, 1999, Journal of immunology.

CD8+ T Cell-Mediated HLA-A*0201-Restricted Cytotoxicity to Transaldolase Peptide 168–176 in Patients with Multiple Sclerosis1

A. Perl, W. Biddison, K. Bánki, 2005, The Journal of Immunology.

ZNF143 Mediates Basal and Tissue-specific Expression of Human Transaldolase*

A. Perl, Yueming Qian, K. Bánki, 2004, Journal of Biological Chemistry.

Pfizer–biontech COVID-19 RNA vaccination induces phosphatidylserine autoantibodies, cryoglobulinemia, and digital necrosis in a patient with pre-existing autoimmunity

A. Perl, K. Bánki, B. Poiesz, 2021, Clinical Immunology Communications.

Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus.

S. Landas, A. Perl, Z. Oaks, 2015, Clinical Immunology.

Cloning and Expression of the Human Gene for Transaldolase

K. Bánki, D. Halladay, Andras PerlS, 2001 .

Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/Rab4 expression and mTOR activation.

N. Huang, E. Poeschla, T. Caza, 2019, JCI insight.

Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood.

J. Shuster, M. Link, S. Morris, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing.

F. Middleton, D. Karp, G. Nagy, 2008, The Biochemical journal.

Cytosolic aldose metabolism contributes to progression from cirrhosis to hepatocarcinogenesis

F. Middleton, S. Landas, J. Asara, 2023, Nature Metabolism.

Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature.

A. Perl, K. Bánki, E. Bonilla, 2020, Annals of translational medicine.

Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity

A. Perl, P. Ferrante, P. Phillips, 1999, Immunogenetics.

Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine.

F. Middleton, S. Landas, G. Vas, 2009, The Journal of clinical investigation.

Liposomal Daunorubicin and Cytarabine, a Potential Therapy for Blastic Plasmacytoid Dendritic Cell Neoplasm

K. Bánki, Gayatri Pemmasani, P. Ashok Kumar, 2022, Journal of investigative medicine high impact case reports.

Transaldolase haploinsufficiency in subjects with acetaminophen‐induced liver failure

William M. Lee, A. Perl, L. Szőnyi, 2019, Journal of inherited metabolic disease.

mTOR-dependent loss of PON1 secretion and antiphospholipid autoantibody production underlie autoimmunity-mediated cirrhosis in transaldolase deficiency.

J. Asara, K. Bánki, T. Winans, 2023, Journal of autoimmunity.

This information is current as Sclerosis Patients Retention of Antigenicity for Multiple Causes the Loss of Enzymatic Activity with Cleavage of Transaldolase by Granzyme B

J. Lieberman, D. Martinvalet, A. Perl, 2010 .

Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation

Z. Oaks, K. Bánki, Nick Huang, 2024, Nature communications.

IL-17A inhibitor-induced leucocytoclastic vasculitis is responsive to IL-23 blockade in a psoriatic arthritis patient

K. Bánki, Pooja Poudel, Andras Perl, 2023, Annals of the Rheumatic Diseases.